 |
| Emma Lynn |
Edelman has recruited Pfizer UK’s corporate affairs director Emma Lynn as global health deputy.
Lynn, who did a 16-year run at Pfizer, reports to Kirsty Graham, head of the specialized global health offering.
She also put in stints at GSK and Burson-Marsteller.
Edelman Health chalked up a robust performance during the 2020 pandemic year as fee income rose 9.1 percent to $168.8M. The firm is No. 2 behind Real Chemistry, the former W2O Group, on O’Dwyer’s roster of healthcare firms.
Edelman also added Lynda Gordon as executive VP, global DXI Health lead.
Gordon joins from the VP-analytics post at Merkle and reports to Yannis Kotziagkiaouridis, global chief data and analytics officer.
Charlie Chapman, a policy advisor to Health & Human Services Secretary Robert Kennedy Jr., has joined BGR’s health & life sciences practice.
The future of DTC should foster understanding and trust, as well as improving clinical conversations.
Healing the Sick Care System: Why People Matter, a new book from FINN Partners chair global health and purpose Gil Bashe, says that the current healthcare system is not broken because it lacks innovation, talent or investment, but because it has lost sight of the people it exists to serve.
